SCHEMBL8447273

SCHEMBL8447273

O=C(NC(=S)Nc1cccc(OC2Cc3ccccc3C2)c1)c1ccnn1C1=CC=CCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.36
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
P2RX2 Q9UBL9 1/20 0.34
ALDH1A1 P00352 7/20 0.34
RAB9A P51151 7/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
ALOX12 P18054 3/20 0.33
MAPT P10636 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NPC1 O15118 5/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
LMNA P02545 2/20 0.33
CYP2D6 P10635 1/20 0.32
SLC9A3 P48764 1/20 0.32
DUSP1 P28562 1/20 0.32
F2 P00734 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2865942 0.85 BRAF (0.49) BRAFALDH1A1RAB9AMEN1KMT2A
SCHEMBL8450229 0.82 RAB9A (0.43) PRMT5WDR77ALDH1A1RAB9AMEN1
SCHEMBL14096213 0.74 ALDH1A1 (0.41) P2RX2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL8449792 0.73 ALDH1A1 (0.41) ALDH1A1RAB9AKDM4ETDP1MAPT
SCHEMBL4373622 0.73 ALDH1A1 (0.47) P2RX2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL2862874 0.72 ALDH1A1 (0.57) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL4361359 0.72 KDR (0.46) ALDH1A1RAB9AMEN1KMT2ATDP1
SCHEMBL4375305 0.72 NPC1 (0.59) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL4369912 0.71 KDR (0.45) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL2910887 0.70 ALDH1A1 (0.56) ALDH1A1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365068-B2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2008-04-29 US disclosed
US-20060025416-A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025416-A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication PIGS, NAT1, AADAC BRAF 4371/4885PRMT5 2836/4885WDR77 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.